One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.

The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
 Type of Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders
 Distribution by Route of Administration
 Oral Route
 Rectal Route
 Intravesical Route
 Topical Route

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The “Bacteriophage Therapies Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
 Adaptive Phage Therapeutics
 ContaFect
 Eliava BioPreparations
 Micreos
 NPO Microgen
 Phagelux
 Pherecydes Pharma

Table of Content

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. BACTERIO-PHAGE THERAPY: MARKET LANDSCAPE

5. BACTERIO-PHAGE THERAPEUTICS: DEVELOPER LANDSCAPE

6. COMPANY AND DRUG PROFILES

7. CLINICAL TRIAL ANALYSIS

8. PATENT ANALYSIS

9. PUBLICATION BENCHMARKING ANALYSIS

10. ACADEMIC GRANTS ANALYSIS

11. FUNDING AND INVESTMENT ANALYSIS

12. PARTNERSHIPS AND COLLABORATIONS

13. START-UP HEALTH INDEXING

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html

Learn from experts: do you know about these emerging industry trends?
How Can Quantum Computing Technology Help In Pharmaceutical R&D?
The Future of Drug Delivery: Exploring Large Volume Wearable Injectors
13 Approved Bispecific Antibodies: Success Stories in Cancer Immunotherapy and Beyond

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]